Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus

Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.

Detalles Bibliográficos
Autores principales: Pavlou, Panagiotis, Koutroukas, Vaios, Lissett, Catherine, Smith, Jamie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517595/
https://www.ncbi.nlm.nih.gov/pubmed/34691455
http://dx.doi.org/10.1002/ccr3.4830
Descripción
Sumario:Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.

Ejemplares similares